Corneal neovascularisation is defined as extension of blood vessels into the avascular stroma. The most common diseases associated with corneal neovascularisation include infectious keratitis, stromal ulceration, inflammatory disorders, alkali burns, contact lens-related hypoxia, corneal graft rejection and limbal stem cell deficiency.1 Riboflavin/ultraviolet A (UVA) crosslinking (CXL) is a technique that was introduced several years ago for the treatment of keratectasia, keratoconus and infectious keratitis.2 Herein, we report a case of extensive corneal neovascularisation which was treated by ultraviolet corneal collagen CXL. Corneal collagen CXL could be an enormous hope in the treatment of corneal neovascularisation mentioning the limitations and undesirable side effects of the current treatment options for it. To our knowledge, this is the first report of using CXL to treat corneal neovascularisation.

العنوان

European Ophthalmic Review

الناشر

European Ophthalmic Review

بلد الناشر

فلسطين

نوع المنشور

Both (Printed and Online)

المجلد

11

السنة

--

الصفحات

--